SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-671945
Filing Date
2016-08-04
Accepted
2016-08-04 16:47:03
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d201090d10q.htm 10-Q 673496
2 EX-10.1 d201090dex101.htm EX-10.1 191236
3 EX-10.2 d201090dex102.htm EX-10.2 332727
4 EX-10.3 d201090dex103.htm EX-10.3 332613
5 EX-31.1 d201090dex311.htm EX-31.1 8918
6 EX-31.2 d201090dex312.htm EX-31.2 8947
7 EX-32.1 d201090dex321.htm EX-32.1 3934
8 EX-32.2 d201090dex322.htm EX-32.2 3997
15 GRAPHIC g201090tx19rider.jpg GRAPHIC 87983
  Complete submission text file 0001193125-16-671945.txt   4464294

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alny-20160630.xml EX-101.INS 650133
10 XBRL TAXONOMY EXTENSION SCHEMA alny-20160630.xsd EX-101.SCH 35784
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20160630_cal.xml EX-101.CAL 52838
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20160630_def.xml EX-101.DEF 207408
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20160630_lab.xml EX-101.LAB 297104
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20160630_pre.xml EX-101.PRE 235957
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 161808124
SIC: 2834 Pharmaceutical Preparations